Search form

Secondary menu

Indication Finder

Indication Finder™: A Repurposing Hunt

In keeping with our commitment to crowdsourcing and transparency, we invite you to participate in a unique exercise. The U.S. National Center for Advancing Translational Sciences (NCATS), a division of NIH, has posted a list of 58 clinical stage compounds that were, until recently, being developed by pharmaceutical companies for various indications. We expect that some of these compounds would be good candidates for Transparency Life Sciences’ approach to drug development. We need your help in deciding which to pursue and the indications you think could be most promising. Our Indication Finder™ (TLS-IF) has been developed to assist in this process. Here's how it works:

NCATS has linked useful background information to the descriptions of all compounds. Once you have familiarized yourself with the compound and its background, the TLS-IF should take only 10-15 minutes to complete. There is no limit to how many you can try.

The compounds you help select using TLS-IF may become TLS development projects. If so, they will be developed using Protocol Builder™, TLS’s proprietary crowdsourcing platform for designing better clinical trials.

To get started:
Please review the list and identify the compounds you believe have potential for further development. Once you have reviewed enough information to assess the compound, complete an Indication Finder for each compound of interest, telling us how you think we should develop the compound along with the basis for your recommendations. Feel free to provide your views on multiple compounds. Happy hunting!